BioSyent Inc. (OTCMKTS:BIOYF) Short Interest Down 56.4% in February

BioSyent Inc. (OTCMKTS:BIOYF) saw a significant drop in short interest in February. As of February 15th, there was short interest totalling 1,700 shares, a drop of 56.4% from the January 31st total of 3,900 shares. Based on an average daily trading volume, of 1,600 shares, the days-to-cover ratio is currently 1.1 days.

BioSyent Stock Up 0.7 %

Shares of BIOYF traded up $0.06 during midday trading on Friday, reaching $7.77. 686 shares of the stock were exchanged, compared to its average volume of 3,836. BioSyent has a twelve month low of $5.93 and a twelve month high of $8.90. The stock’s 50 day simple moving average is $7.75 and its 200 day simple moving average is $7.89.

BioSyent Increases Dividend

The company also recently announced a dividend, which will be paid on Friday, March 14th. Stockholders of record on Monday, March 3rd will be issued a dividend of $0.0347 per share. The ex-dividend date is Friday, February 28th. This represents a dividend yield of 1.77%. This is an increase from BioSyent’s previous dividend of $0.03.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.